Erratum: Concurrent capecitabine and whole-brain radiotherapy for treatment of brain metastases in breast cancer patients (Journal of Neuro-Oncology 10.1007/s11060-008-9791-2);Concurrent capecitabine and whole-brain radiotherapy for treatment of brain metastases in breast cancer patients

Journal of Neuro-Oncology

Volumn 93, Issue 3, 2009, Pages 379-384

  Chargari, Cyrus ^a   Kirova, Youlia M ^a   Diéras, Véronique ^a   Pena, Pablo Castro ^a   Campana, Francois ^a   Cottu, Paul H ^a   Pierga, Jean Yves ^a   Fourquet, Alain ^a  

^a INSTITUT CURIE   (France)

Author keywords

Breast cancer; Capecitabine; Chemoradiation; Whole brain radiotherapy

Indexed keywords

AMINOGLUTETHIMIDE; ANASTROZOLE; ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CAPECITABINE; CISPLATIN; COBALT; CYCLOPHOSPHAMIDE; DOCETAXEL; EPIRUBICIN; ESTRAMUSTINE; ETOPOSIDE; EXEMESTANE; FLUOROURACIL; GADOLINIUM; GOSERELIN; IFOSFAMIDE; LETROZOLE; MEDROXYPROGESTERONE; METHOTREXATE; MITOMYCIN C; MITOXANTRONE; NAVELBINE; PACLITAXEL; PIRARUBICIN; TAMOXIFEN; TOREMIFENE;

ADJUVANT THERAPY; ADULT; ALOPECIA; ANEMIA; ARTICLE; BRACHYTHERAPY; BRAIN METASTASIS; BREAST CANCER; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; HAND FOOT SYNDROME; HEADACHE; HORMONAL THERAPY; HUMAN; LIVER METASTASIS; LUNG METASTASIS; MASTECTOMY; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; RADIATION DOSE; RETROSPECTIVE STUDY; SEPTIC SHOCK; TREATMENT RESPONSE; WHOLE BRAIN RADIOTHERAPY;

EID: 67349192199     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-009-9852-1     Document Type: Erratum

References (27)

1. Weil RJ, Palmieri DC, Bronder JL et al (2005) Breast cancer metastasis to the central nervous system. Am J Pathol 167:913-920
2. Tsukada Y, Fouad A, Pickren JW et al (1983) Central nervous system metastasis from breast carcinoma. Autopsy study. Cancer 52:2349-2354. doi:10.1002/ 1097-0142(19831215)52:12<2349::AID-CNCR2820521231>3.0.CO;2-B
3. Borgelt B, Gelber R, Kramer S et al (1980) The palliation of brain metastases: Final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 6:1-9
4. Sawada N, Ishikawa T, Sekiguchi F et al (1999) X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts. Clin Cancer Res 5:2948-2953
5. Wang MLH, Yung WKA, Royce ME et al (2001) Capecitabine for 5-fluorouracil resistant brain metastases from breast cancer. Am J Clin Oncol 24:421-424. doi: 10.1097/00000421-200108000-00026
6. Rogers LR, Remer SE, Tejwani S (2004) Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy. Neuro-oncol 6:63-64. doi: 10.1215/S1152851703000334
7. Giglio P, Tremont-Lukats IW, Groves MD (2003) Response of neoplastic meningitis from solid tumors to oral capecitabine. J Neurooncol 65:167-172. doi: 10.1023/B:NEON.0000003752.89814.ca
8. Tham YL, Hinckley L, Teh BS et al (2006) Long-term clinical response in leptomeningeal metastases from breast cancer treated with capecitabine monotherapy: A case report. Clin Breast Cancer 7:164-166. doi: 10.3816/ CBC.2006.n.028
9. Siegelmann-Danieli N, Stein M, Bar-Ziv J (2003) Complete response of brain metastases originating in breast cancer to capecitabine therapy. Isr Med Assoc J 5:833-834
10. Fabi A, Vidiri A, Ferretti G et al (2006) Dramatic regression of multiple brain metastases from breast cancer with capecitabine: Another arrow at the bow? Cancer Invest 24:466-468. doi: 10.1080/ 07357900600705805
11. Miwa M, Ura M, Nishida M et al (1998) Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue. Eur J Cancer 34:1274-1281. doi: 10.1016/S0959-8049(98)00058-6
12. Gaspar L, Scott C, Rotman M (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 43:745-751. doi: 10.1016/S0360-3016(96)00619-0
13. Murray KJ, Scott C, Greenberg HM et al (1997) A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: A report of the Radiation Therapy Oncology Group (RTOG) 9104. Int J Radiat Oncol Biol Phys 39:571-574. doi: 10.1016/ S0360-3016(97)00341-6
14. DeAngelis LM, Delattre JY, Posner JB (1989) Radiation-induced dementia in patients cured of brain metastases. Neurology 39:789-796
15. Wadasadawala T, Gupta S, Bagul V, Patil N (2007) Brain metastases from breast cancer: Management approach. J Cancer Res Ther 3:157-165
16. Pinedo HM, Peters GF (1988) Fluorouracil: Biochemistry and pharmacology. J Clin Oncol 6:1653-1664
17. Seiwert TY, Salama JK, Vokes EE (2007) The concurrent chemoradiation paradigm - general principles. Nat Clin Pract Oncol 4:86-100. doi: 10.1038/ncponc0714
18. Lawrence TS, Tepper JE, Blackstock AW (1997) Fluoropyrimidine-radiation interactions in cells and tumors. Semin Radiat Oncol 7:260-266. doi: 10.1016/S1053-4296(97)80024-0
19. McGinn CJ, Lawrence TS (2001) Recent advances in the use of radiosensitizing nucleosides. Semin Radiat Oncol 11:270-280. doi: 10.1053/srao.2001.26002
20. McEvoy GK (ed) (2002) Capecitabine. In: AHFS drug information. American Society of Health-System Pharmacists, Bethesda, MD, pp 916-921
21. Heier MS, Heintz R, Fossa SD (1986) Passage of 50-dFUrd and its metabolites 5-FU and 5-FUH2 to CSF in a clinical phase 1 study. Acta Neurol Scand 74:240-244
22. Loo WT, Sasano H, Chow LW (2007) Evaluation of therapeutic efficacy of capecitabine on human breast carcinoma tissues and cell lines in vitro. Biomed Pharmacother 61:553-557. doi: 10.1016/j.biopha.2007.08.014
23. Ekenel M, Hormigo AM, Peak S, Deangelis LM, Abrey LE (2007) Capecitabine therapy of central nervous system metastases from breast cancer. J Neurooncol 85:223-227. doi: 10.1007/s11060-007-9409-0
24. Rivera E, Meyers C, Groves M et al (2006) Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma. Cancer 107:1348-1354. doi: 10.1002/ cncr.22127
25. Addeo R, Caraglia M, Faiola V et al (2007) Concomitant treatment of brain metastasis with whole brain radiotherapy [WBRT] and temozolomide [TMZ] is active and improves quality of life. BMC Cancer 7:18. doi: 10.1186/1471-2407-7-18
26. Carmona-Bayonas A (2007) Concurrent radiotherapy and capecitabine, followed by high-dose methotrexate consolidation, provided effective palliation in a patient with leptomeningeal metastases from breast cancer. Ann Oncol 18:199-200. doi: 10.1093/annonc/mdl290
27. Hikino H, Yamada T, Johbara K et al (2006) Potential role of chemo-radiation with oral capecitabine in a breast cancer patient with central nervous system relapse. Breast 15:97-99. doi: 10.1016/ j.breast.2005.03.006